Alexander James Layden, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 4 | 2023 | 1726 | 0.850 |
Why?
|
| Chorioamnionitis | 1 | 2023 | 154 | 0.790 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2018 | 119 | 0.690 |
Why?
|
| Tropical Medicine | 1 | 2018 | 52 | 0.600 |
Why?
|
| Neglected Diseases | 1 | 2018 | 67 | 0.590 |
Why?
|
| Helminthiasis | 1 | 2018 | 81 | 0.580 |
Why?
|
| Vitamin B 12 | 3 | 2024 | 531 | 0.570 |
Why?
|
| Transcobalamins | 1 | 2016 | 22 | 0.540 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 587 | 0.530 |
Why?
|
| Infant, Premature, Diseases | 1 | 2022 | 712 | 0.520 |
Why?
|
| Premature Birth | 1 | 2022 | 1830 | 0.330 |
Why?
|
| Gestational Sac | 1 | 2021 | 17 | 0.190 |
Why?
|
| Selection Bias | 1 | 2023 | 359 | 0.190 |
Why?
|
| Interleukin-15 | 1 | 2020 | 186 | 0.160 |
Why?
|
| Abortion, Spontaneous | 1 | 2024 | 536 | 0.160 |
Why?
|
| Ebolavirus | 1 | 2020 | 250 | 0.150 |
Why?
|
| Fetal Growth Retardation | 1 | 2022 | 591 | 0.150 |
Why?
|
| Pregnancy | 6 | 2024 | 30236 | 0.150 |
Why?
|
| Dengue | 1 | 2020 | 258 | 0.130 |
Why?
|
| Milk, Human | 1 | 2020 | 490 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2020 | 424 | 0.120 |
Why?
|
| Anemia | 1 | 2024 | 1514 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1353 | 0.110 |
Why?
|
| Perinatal Care | 1 | 2015 | 244 | 0.100 |
Why?
|
| Inflammation | 2 | 2023 | 10863 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2020 | 1363 | 0.100 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 395 | 0.100 |
Why?
|
| Fetal Blood | 1 | 2016 | 1367 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2020 | 2594 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2023 | 13050 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2024 | 26387 | 0.070 |
Why?
|
| Female | 8 | 2024 | 396532 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5943 | 0.050 |
Why?
|
| Obesity | 1 | 2023 | 13090 | 0.040 |
Why?
|
| Humans | 10 | 2024 | 766812 | 0.040 |
Why?
|
| Orosomucoid | 1 | 2020 | 45 | 0.040 |
Why?
|
| Ecuador | 1 | 2020 | 62 | 0.040 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2020 | 94 | 0.040 |
Why?
|
| Dietary Supplements | 2 | 2024 | 3429 | 0.030 |
Why?
|
| Body Size | 1 | 2020 | 461 | 0.030 |
Why?
|
| Ferritins | 1 | 2020 | 601 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2021 | 917 | 0.030 |
Why?
|
| Micronutrients | 1 | 2020 | 390 | 0.030 |
Why?
|
| Vitamins | 1 | 2024 | 1631 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 74889 | 0.030 |
Why?
|
| Fetus | 1 | 2021 | 1878 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 1607 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 88902 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2020 | 1621 | 0.020 |
Why?
|
| Infant | 2 | 2024 | 36459 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3853 | 0.020 |
Why?
|
| Communication | 1 | 2022 | 3905 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 168939 | 0.020 |
Why?
|
| Vitamin D | 1 | 2020 | 3270 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 2971 | 0.010 |
Why?
|
| Child | 2 | 2024 | 80670 | 0.010 |
Why?
|
| Young Adult | 2 | 2022 | 59939 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10384 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22248 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2024 | 42577 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26309 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 54872 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 223305 | 0.000 |
Why?
|
| Male | 1 | 2020 | 364154 | 0.000 |
Why?
|